Reviews - 4zyp mentioned but not cited (3)
- Approved Antiviral Drugs over the Past 50 Years. De Clercq E, Li G. Clin Microbiol Rev 29 695-747 (2016)
- Antibody Epitopes of Pneumovirus Fusion Proteins. Huang J, Diaz D, Mousa JJ. Front Immunol 10 2778 (2019)
- Structural Insight into Paramyxovirus and Pneumovirus Entry Inhibition. Aggarwal M, Plemper RK. Viruses 12 E342 (2020)
Articles - 4zyp mentioned but not cited (10)
- A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein. Mousa JJ, Kose N, Matta P, Gilchuk P, Crowe JE. Nat Microbiol 2 16271 (2017)
- Antigenic Fingerprinting following Primary RSV Infection in Young Children Identifies Novel Antigenic Sites and Reveals Unlinked Evolution of Human Antibody Repertoires to Fusion and Attachment Glycoproteins. Fuentes S, Coyle EM, Beeler J, Golding H, Khurana S. PLoS Pathog 12 e1005554 (2016)
- Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial Virus. Boyington JC, Joyce MG, Sastry M, Stewart-Jones GB, Chen M, Kong WP, Ngwuta JO, Thomas PV, Tsybovsky Y, Yang Y, Zhang B, Chen L, Druz A, Georgiev IS, Ko K, Zhou T, Mascola JR, Graham BS, Kwong PD. PLoS One 11 e0159709 (2016)
- Alternative conformations of a major antigenic site on RSV F. Jones HG, Battles MB, Lin CC, Bianchi S, Corti D, McLellan JS. PLoS Pathog 15 e1007944 (2019)
- Antigenic and sequence variability of the human respiratory syncytial virus F glycoprotein compared to related viruses in a comprehensive dataset. Mas V, Nair H, Campbell H, Melero JA, Williams TC. Vaccine 36 6660-6673 (2018)
- Multi-state design of flexible proteins predicts sequences optimal for conformational change. Sauer MF, Sevy AM, Crowe JE, Meiler J. PLoS Comput Biol 16 e1007339 (2020)
- Structural and Nonstructural Viral Proteins Are Targets of T-Helper Immune Response against Human Respiratory Syncytial Virus. Lorente E, Barriga A, Barnea E, Mir C, Gebe JA, Admon A, López D. Mol Cell Proteomics 15 2141-2151 (2016)
- Molecular Modeling Predicts Novel Antibody Escape Mutations in the Respiratory Syncytial Virus Fusion Glycoprotein. Beach SS, Hull MA, Ytreberg FM, Patel JS, Miura TA. J Virol 96 e0035322 (2022)
- A morphological transformation in respiratory syncytial virus leads to enhanced complement deposition. Kuppan JP, Mitrovich MD, Vahey MD. Elife 10 e70575 (2021)
- Improved epitope resolution of the prefusion trimer-specific antibody AM14 bound to the RSV F glycoprotein. Harshbarger W, Abeyrathne PD, Tian S, Huang Y, Chandramouli S, Bottomley MJ, Malito E. MAbs 13 1955812 (2021)
Reviews citing this publication (14)
- Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias? Cagno V, Tseligka ED, Jones ST, Tapparel C. Viruses 11 E596 (2019)
- Respiratory syncytial virus entry and how to block it. Battles MB, McLellan JS. Nat Rev Microbiol 17 233-245 (2019)
- Structural, antigenic and immunogenic features of respiratory syncytial virus glycoproteins relevant for vaccine development. Melero JA, Mas V, McLellan JS. Vaccine 35 461-468 (2017)
- Human respiratory syncytial virus: pathogenesis, immune responses, and current vaccine approaches. Taleb SA, Al Thani AA, Al Ansari K, Yassine HM. Eur J Clin Microbiol Infect Dis 37 1817-1827 (2018)
- Stable long-term cultures of self-renewing B cells and their applications. Kwakkenbos MJ, van Helden PM, Beaumont T, Spits H. Immunol Rev 270 65-77 (2016)
- Development and clinical applications of novel antibodies for prevention and treatment of respiratory syncytial virus infection. Mejias A, Garcia-Maurino C, Rodriguez-Fernandez R, Peeples ME, Ramilo O. Vaccine 35 496-502 (2017)
- Determinants of early life immune responses to RSV infection. Ruckwardt TJ, Morabito KM, Graham BS. Curr Opin Virol 16 151-157 (2016)
- Epitope-focused vaccine design against influenza A and B viruses. Ren H, Zhou P. Curr Opin Immunol 42 83-90 (2016)
- Respiratory syncytial virus vaccine: where are we now and what comes next? Noor A, Krilov LR. Expert Opin Biol Ther 18 1247-1256 (2018)
- New Insights Contributing to the Development of Effective Vaccines and Therapies to Reduce the Pathology Caused by hRSV. Gálvez NMS, Soto JA, Kalergis AM. Int J Mol Sci 18 E1753 (2017)
- Influence of antigen conformation and mode of presentation on the antibody and protective responses against human respiratory syncytial virus: relevance for vaccine development. Melero JA. Expert Rev Vaccines 15 1319-1325 (2016)
- Heparin mimetics as potential intervention for COVID-19 and their bio-manufacturing. Jiang L, Zhang T, Lu H, Li S, Lv K, Tuffour A, Zhang L, Ding K, Li JP, Li H, Liu X. Synth Syst Biotechnol 8 11-19 (2023)
- Importance of Virus Characteristics in Respiratory Syncytial Virus-Induced Disease. San-Juan-Vergara H, Peeples ME. Immunol Allergy Clin North Am 39 321-334 (2019)
- The RSV F p27 peptide: current knowledge, important questions. Rezende W, Neal HE, Dutch RE, Piedra PA. Front Microbiol 14 1219846 (2023)
Articles citing this publication (57)
- Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera. Ngwuta JO, Chen M, Modjarrad K, Joyce MG, Kanekiyo M, Kumar A, Yassine HM, Moin SM, Killikelly AM, Chuang GY, Druz A, Georgiev IS, Rundlet EJ, Sastry M, Stewart-Jones GB, Yang Y, Zhang B, Nason MC, Capella C, Peeples ME, Ledgerwood JE, McLellan JS, Kwong PD, Graham BS. Sci Transl Med 7 309ra162 (2015)
- Structural and molecular basis for Ebola virus neutralization by protective human antibodies. Misasi J, Gilman MS, Kanekiyo M, Gui M, Cagigi A, Mulangu S, Corti D, Ledgerwood JE, Lanzavecchia A, Cunningham J, Muyembe-Tamfun JJ, Baxa U, Graham BS, Xiang Y, Sullivan NJ, McLellan JS. Science 351 1343-1346 (2016)
- Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape. Wang L, Shi W, Chappell JD, Joyce MG, Zhang Y, Kanekiyo M, Becker MM, van Doremalen N, Fischer R, Wang N, Corbett KS, Choe M, Mason RD, Van Galen JG, Zhou T, Saunders KO, Tatti KM, Haynes LM, Kwong PD, Modjarrad K, Kong WP, McLellan JS, Denison MR, Munster VJ, Mascola JR, Graham BS. J Virol 92 e02002-17 (2018)
- A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants. Zhu Q, McLellan JS, Kallewaard NL, Ulbrandt ND, Palaszynski S, Zhang J, Moldt B, Khan A, Svabek C, McAuliffe JM, Wrapp D, Patel NK, Cook KE, Richter BWM, Ryan PC, Yuan AQ, Suzich JA. Sci Transl Med 9 eaaj1928 (2017)
- Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors. Gilman MS, Castellanos CA, Chen M, Ngwuta JO, Goodwin E, Moin SM, Mas V, Melero JA, Wright PF, Graham BS, McLellan JS, Walker LM. Sci Immunol 1 eaaj1879 (2016)
- Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV. Joyce MG, Zhang B, Ou L, Chen M, Chuang GY, Druz A, Kong WP, Lai YT, Rundlet EJ, Tsybovsky Y, Yang Y, Georgiev IS, Guttman M, Lees CR, Pancera M, Sastry M, Soto C, Stewart-Jones GBE, Thomas PV, Van Galen JG, Baxa U, Lee KK, Mascola JR, Graham BS, Kwong PD. Nat Struct Mol Biol 23 811-820 (2016)
- Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus. Killikelly AM, Kanekiyo M, Graham BS. Sci Rep 6 34108 (2016)
- Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens. Ueda G, Antanasijevic A, Fallas JA, Sheffler W, Copps J, Ellis D, Hutchinson GB, Moyer A, Yasmeen A, Tsybovsky Y, Park YJ, Bick MJ, Sankaran B, Gillespie RA, Brouwer PJ, Zwart PH, Veesler D, Kanekiyo M, Graham BS, Sanders RW, Moore JP, Klasse PJ, Ward AB, King NP, Baker D. Elife 9 e57659 (2020)
- Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection. Espeseth AS, Cejas PJ, Citron MP, Wang D, DiStefano DJ, Callahan C, Donnell GO, Galli JD, Swoyer R, Touch S, Wen Z, Antonello J, Zhang L, Flynn JA, Cox KS, Freed DC, Vora KA, Bahl K, Latham AH, Smith JS, Gindy ME, Ciaramella G, Hazuda D, Shaw CA, Bett AJ. NPJ Vaccines 5 16 (2020)
- Vaccines against respiratory syncytial virus: The time has finally come. Graham BS. Vaccine 34 3535-3541 (2016)
- A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation. Stobart CC, Rostad CA, Ke Z, Dillard RS, Hampton CM, Strauss JD, Yi H, Hotard AL, Meng J, Pickles RJ, Sakamoto K, Lee S, Currier MG, Moin SM, Graham BS, Boukhvalova MS, Gilbert BE, Blanco JC, Piedra PA, Wright ER, Moore ML. Nat Commun 7 13916 (2016)
- Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state. Rossey I, Gilman MS, Kabeche SC, Sedeyn K, Wrapp D, Kanekiyo M, Chen M, Mas V, Spitaels J, Melero JA, Graham BS, Schepens B, McLellan JS, Saelens X. Nat Commun 8 14158 (2017)
- Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus. Wen X, Mousa JJ, Bates JT, Lamb RA, Crowe JE, Jardetzky TS. Nat Microbiol 2 16272 (2017)
- Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B. Hause AM, Henke DM, Avadhanula V, Shaw CA, Tapia LI, Piedra PA. PLoS One 12 e0175792 (2017)
- Broadly Reactive Anti-Respiratory Syncytial Virus G Antibodies from Exposed Individuals Effectively Inhibit Infection of Primary Airway Epithelial Cells. Cortjens B, Yasuda E, Yu X, Wagner K, Claassen YB, Bakker AQ, van Woensel JBM, Beaumont T. J Virol 91 e02357-16 (2017)
- Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV. Widjaja I, Wicht O, Luytjes W, Leenhouts K, Rottier PJM, van Kuppeveld FJM, Haijema BJ, de Haan CAM. J Virol 90 5965-5977 (2016)
- Protection of calves by a prefusion-stabilized bovine RSV F vaccine. Zhang B, Chen L, Silacci C, Thom M, Boyington JC, Druz A, Joyce MG, Guzman E, Kong WP, Lai YT, Stewart-Jones GBE, Tsybovsky Y, Yang Y, Zhou T, Baxa U, Mascola JR, Corti D, Lanzavecchia A, Taylor G, Kwong PD. NPJ Vaccines 2 7 (2017)
- Transient opening of trimeric prefusion RSV F proteins. Gilman MSA, Furmanova-Hollenstein P, Pascual G, B van 't Wout A, Langedijk JPM, McLellan JS. Nat Commun 10 2105 (2019)
- Conformational Plasticity in the HIV-1 Fusion Peptide Facilitates Recognition by Broadly Neutralizing Antibodies. Yuan M, Cottrell CA, Ozorowski G, van Gils MJ, Kumar S, Wu NC, Sarkar A, Torres JL, de Val N, Copps J, Moore JP, Sanders RW, Ward AB, Wilson IA. Cell Host Microbe 25 873-883.e5 (2019)
- Influence of Respiratory Syncytial Virus F Glycoprotein Conformation on Induction of Protective Immune Responses. Palomo C, Mas V, Thom M, Vázquez M, Cano O, Terrón MC, Luque D, Taylor G, Melero JA. J Virol 90 5485-5498 (2016)
- Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion protein. Mousa JJ, Sauer MF, Sevy AM, Finn JA, Bates JT, Alvarado G, King HG, Loerinc LB, Fong RH, Doranz BJ, Correia BE, Kalyuzhniy O, Wen X, Jardetzky TS, Schief WR, Ohi MD, Meiler J, Crowe JE. Proc Natl Acad Sci U S A 113 E6849-E6858 (2016)
- Improved Prefusion Stability, Optimized Codon Usage, and Augmented Virion Packaging Enhance the Immunogenicity of Respiratory Syncytial Virus Fusion Protein in a Vectored-Vaccine Candidate. Liang B, Ngwuta JO, Surman S, Kabatova B, Liu X, Lingemann M, Liu X, Yang L, Herbert R, Swerczek J, Chen M, Moin SM, Kumar A, McLellan JS, Kwong PD, Graham BS, Collins PL, Munir S. J Virol 91 e00189-17 (2017)
- Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein. Cimica V, Boigard H, Bhatia B, Fallon JT, Alimova A, Gottlieb P, Galarza JM. Clin Vaccine Immunol 23 451-459 (2016)
- Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector. Liang B, Ngwuta JO, Herbert R, Swerczek J, Dorward DW, Amaro-Carambot E, Mackow N, Kabatova B, Lingemann M, Surman S, Yang L, Chen M, Moin SM, Kumar A, McLellan JS, Kwong PD, Graham BS, Schaap-Nutt A, Collins PL, Munir S. J Virol 90 10022-10038 (2016)
- Pre-fusion RSV F strongly boosts pre-fusion specific neutralizing responses in cattle pre-exposed to bovine RSV. Steff AM, Monroe J, Friedrich K, Chandramouli S, Nguyen TL, Tian S, Vandepaer S, Toussaint JF, Carfi A. Nat Commun 8 1085 (2017)
- Human antibody recognition of antigenic site IV on Pneumovirus fusion proteins. Mousa JJ, Binshtein E, Human S, Fong RH, Alvarado G, Doranz BJ, Moore ML, Ohi MD, Crowe JE. PLoS Pathog 14 e1006837 (2018)
- Trivalency of a Nanobody Specific for the Human Respiratory Syncytial Virus Fusion Glycoprotein Drastically Enhances Virus Neutralization and Impacts Escape Mutant Selection. Palomo C, Mas V, Detalle L, Depla E, Cano O, Vázquez M, Stortelers C, Melero JA. Antimicrob Agents Chemother 60 6498-6509 (2016)
- Micro-fusion inhibition tests: quantifying antibody neutralization of virus-mediated cell-cell fusion. Thakur N, Conceicao C, Isaacs A, Human S, Modhiran N, McLean RK, Pedrera M, Tan TK, Rijal P, Townsend A, Taylor G, Young PR, Watterson D, Chappell KJ, Graham SP, Bailey D. J Gen Virol 102 (2021)
- Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses. Mukhamedova M, Wrapp D, Shen CH, Gilman MSA, Ruckwardt TJ, Schramm CA, Ault L, Chang L, Derrien-Colemyn A, Lucas SAM, Ransier A, Darko S, Phung E, Wang L, Zhang Y, Rush SA, Madan B, Stewart-Jones GBE, Costner PJ, Holman LA, Hickman SP, Berkowitz NM, Doria-Rose NA, Morabito KM, DeKosky BJ, Gaudinski MR, Chen GL, Crank MC, Misasi J, Sullivan NJ, Douek DC, Kwong PD, Graham BS, McLellan JS, Mascola JR. Immunity 54 769-780.e6 (2021)
- Epitope-Specific Serological Assays for RSV: Conformation Matters. Phung E, Chang LA, Morabito KM, Kanekiyo M, Chen M, Nair D, Kumar A, Chen GL, Ledgerwood JE, Graham BS, Ruckwardt TJ. Vaccines (Basel) 7 E23 (2019)
- Comparison of Immune Responses to Different Versions of VLP Associated Stabilized RSV Pre-Fusion F Protein. Cullen LM, Schmidt MR, Torres GM, Capoferri AA, Morrison TG. Vaccines (Basel) 7 E21 (2019)
- Comparison of Palivizumab-Like Antibody Binding to Different Conformations of the RSV F Protein in RSV-Infected Adult Hematopoietic Cell Transplant Recipients. Ye X, Iwuchukwu OP, Avadhanula V, Aideyan LO, McBride TJ, Ferlic-Stark LL, Patel KD, Piedra FA, Shah DP, Chemaly RF, Piedra PA. J Infect Dis 217 1247-1256 (2018)
- Antibody-Induced Internalization of the Human Respiratory Syncytial Virus Fusion Protein. Leemans A, De Schryver M, Van der Gucht W, Heykers A, Pintelon I, Hotard AL, Moore ML, Melero JA, McLellan JS, Graham BS, Broadbent L, Power UF, Caljon G, Cos P, Maes L, Delputte P. J Virol 91 e00184-17 (2017)
- Characterization of potent RSV neutralizing antibodies isolated from human memory B cells and identification of diverse RSV/hMPV cross-neutralizing epitopes. Xiao X, Tang A, Cox KS, Wen Z, Callahan C, Sullivan NL, Nahas DD, Cosmi S, Galli JD, Minnier M, Verma D, Babaoglu K, Su H, Bett AJ, Vora KA, Chen Z, Zhang L. MAbs 11 1415-1427 (2019)
- Development and Standardization of a High-Throughput Multiplex Immunoassay for the Simultaneous Quantification of Specific Antibodies to Five Respiratory Syncytial Virus Proteins. Schepp RM, de Haan CAM, Wilkins D, Layman H, Graham BS, Esser MT, Berbers GAM. mSphere 4 e00236-19 (2019)
- Stability Characterization of a Vaccine Antigen Based on the Respiratory Syncytial Virus Fusion Glycoprotein. Flynn JA, Durr E, Swoyer R, Cejas PJ, Horton MS, Galli JD, Cosmi SA, Espeseth AS, Bett AJ, Zhang L. PLoS One 11 e0164789 (2016)
- A Chimeric Pneumovirus Fusion Protein Carrying Neutralizing Epitopes of Both MPV and RSV. Wen X, Pickens J, Mousa JJ, Leser GP, Lamb RA, Crowe JE, Jardetzky TS. PLoS One 11 e0155917 (2016)
- Discovery and Characterization of Phage Display-Derived Human Monoclonal Antibodies against RSV F Glycoprotein. Chen Z, Zhang L, Tang A, Callahan C, Pristatsky P, Swoyer R, Cejas P, Nahas D, Galli J, Cosmi S, DiStefano D, Hoang VM, Bett A, Casimiro D, Vora KA. PLoS One 11 e0156798 (2016)
- Effect of Previous Respiratory Syncytial Virus Infection on Murine Immune Responses to F and G Protein-Containing Virus-Like Particles. McGinnes Cullen L, Schmidt MR, Morrison TG. J Virol 93 e00087-19 (2019)
- Five Residues in the Apical Loop of the Respiratory Syncytial Virus Fusion Protein F2 Subunit Are Critical for Its Fusion Activity. Hicks SN, Chaiwatpongsakorn S, Costello HM, McLellan JS, Ray W, Peeples ME. J Virol 92 e00621-18 (2018)
- Removal of the N-Glycosylation Sequon at Position N116 Located in p27 of the Respiratory Syncytial Virus Fusion Protein Elicits Enhanced Antibody Responses after DNA Immunization. Leemans A, Boeren M, Van der Gucht W, Pintelon I, Roose K, Schepens B, Saelens X, Bailey D, Martinet W, Caljon G, Maes L, Cos P, Delputte P. Viruses 10 E426 (2018)
- Systematic comparison of respiratory syncytial virus-induced memory B cell responses in two anatomical compartments. Shehata L, Wieland-Alter WF, Maurer DP, Chen E, Connor RI, Wright PF, Walker LM. Nat Commun 10 1126 (2019)
- The respiratory syncytial virus (RSV) prefusion F-protein functional antibody repertoire in adult healthy donors. Andreano E, Paciello I, Bardelli M, Tavarini S, Sammicheli C, Frigimelica E, Guidotti S, Torricelli G, Biancucci M, D'Oro U, Chandramouli S, Bottomley MJ, Rappuoli R, Finco O, Buricchi F. EMBO Mol Med 13 e14035 (2021)
- A vulnerable, membrane-proximal site in human respiratory syncytial virus F revealed by a prefusion-specific single-domain antibody. Rossey I, Hsieh CL, Sedeyn K, Ballegeer M, Schepens B, Mclellan JS, Saelens X. J Virol 95 JVI.02279-20 (2021)
- Comparisons of Antibody Populations in Different Pre-Fusion F VLP-Immunized Cotton Rat Dams and Their Offspring. Cullen LM, Boukhvalova MS, Blanco JCG, Morrison TG. Vaccines (Basel) 8 E133 (2020)
- Identification of a homology-independent linchpin domain controlling mouse and bank vole prion protein conversion. Burke CM, Mark KMK, Walsh DJ, Noble GP, Steele AD, Diack AB, Manson JC, Watts JC, Supattapone S. PLoS Pathog 16 e1008875 (2020)
- Immunogenicity of RSV F DNA Vaccine in BALB/c Mice. Eroglu E, Singh A, Bawage S, Tiwari PM, Vig K, Pillai SR, Dennis VA, Singh SR. Adv Virol 2016 7971847 (2016)
- Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies. Muñoz-Alía MA, Casasnovas JM, Celma ML, Carabaña J, Liton PB, Fernandez-Muñoz R. Virus Res 236 30-43 (2017)
- Murine Pneumonia Virus Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus from an Added Gene Is Highly Attenuated and Immunogenic in Rhesus Macaques. Brock LG, Liu X, Liang B, Lingemann M, Liu X, Herbert R, Hackenberg AD, Buchholz UJ, Collins PL, Munir S. J Virol 92 e00723-18 (2018)
- Convergent structural features of respiratory syncytial virus neutralizing antibodies and plasticity of the site V epitope on prefusion F. Harshbarger W, Tian S, Wahome N, Balsaraf A, Bhattacharya D, Jiang D, Pandey R, Tungare K, Friedrich K, Mehzabeen N, Biancucci M, Chinchilla-Olszar D, Mallett CP, Huang Y, Wang Z, Bottomley MJ, Malito E, Chandramouli S. PLoS Pathog 16 e1008943 (2020)
- Intranasal vaccination with a recombinant protein CTA1-DD-RBF protects mice against hRSV infection. Li H, Ren H, Zhang Y, Cao L, Xu W. Sci Rep 11 18641 (2021)
- Potent Human Single-Domain Antibodies Specific for a Novel Prefusion Epitope of Respiratory Syncytial Virus F Glycoprotein. Xun G, Song X, Hu J, Zhang H, Liu L, Zhang Z, Gong R. J Virol 95 e0048521 (2021)
- In silico virtual screening of lead compounds for major antigenic sites in respiratory syncytial virus fusion protein. Mathew S, Taleb S, Eid AH, Althani AA, Yassine HM. Emergent Mater 5 295-305 (2022)
- Molecular Evolution of Attachment Glycoprotein (G) and Fusion Protein (F) Genes of Respiratory Syncytial Virus ON1 and BA9 Strains in Xiamen, China. Sun YP, Lei SY, Wang YB, Wang YZ, Qiang HS, Yin YF, Jiang ZM, Zhu M, Chen XL, Ye HM, Zheng ZZ, Xia NS. Microbiol Spectr 10 e0208321 (2022)
- The Respiratory Syncytial Virus (RSV) G Protein Enhances the Immune Responses to the RSV F Protein in an Enveloped Virus-Like Particle Vaccine Candidate. McGinnes Cullen L, Luo B, Wen Z, Zhang L, Durr E, Morrison TG. J Virol 97 e0190022 (2023)
- Profiling of hMPV F-specific antibodies isolated from human memory B cells. Xiao X, Fridman A, Zhang L, Pristatsky P, Durr E, Minnier M, Tang A, Cox KS, Wen Z, Moore R, Tian D, Galli JD, Cosmi S, Eddins MJ, Sullivan NL, Yan X, Bett AJ, Su HP, Vora KA, Chen Z, Zhang L. Nat Commun 13 2546 (2022)
- Structural characterization of M8C10, a neutralizing antibody targeting a highly conserved prefusion-specific epitope on the metapneumovirus fusion trimerization interface. Xiao X, Wen Z, Chen Q, Shipman JM, Kostas J, Reid JC, Warren C, Tang A, Luo B, O'Donnell G, Fridman A, Chen Z, Vora KA, Zhang L, Su H-P, Eddins MJ. J Virol 97 e0105223 (2023)